What causes adenomyosis

Overview

Adenomyosis is a common gynecological condition where the tissue that normally lines the uterus, known as the endometrium, grows into the muscular wall of the uterus, called the myometrium. This abnormal growth can cause the uterus to enlarge and become tender, leading to a range of symptoms such as heavy or prolonged menstrual bleeding, severe menstrual cramps (dysmenorrhea), and pain during intercourse (dyspareunia). While the exact mechanisms behind adenomyosis are still being researched, several theories and contributing factors have been identified.

What is Adenomyosis?

In a healthy uterus, the endometrium thickens each month in preparation for a potential pregnancy and is shed during menstruation if pregnancy does not occur. The myometrium is the thick, muscular layer that surrounds the endometrium and is responsible for uterine contractions during labor. In adenomyosis, endometrial tissue invades the myometrium, establishing glands and tissue within the uterine wall. This misplaced tissue responds to hormonal changes just like the regular endometrium, leading to bleeding and inflammation within the uterine muscle.

Potential Causes and Contributing Factors

While a definitive cause for adenomyosis remains elusive, several hypotheses are actively explored by medical researchers. These theories often overlap and may contribute to the development of the condition in different individuals.

Endometrial Invasion Theory

One prominent theory suggests that adenomyosis arises from a disruption of the boundary between the endometrium and the myometrium. This disruption could occur due to various factors, allowing endometrial cells to penetrate the uterine wall. This invasion may be facilitated by:

• Uterine Injury: Procedures that involve manipulation or incision of the uterus, such as Cesarean sections (C-sections), myomectomy (fibroid removal), or dilation and curettage (D&C), may create pathways for endometrial tissue to enter the myometrium. Studies have shown a higher incidence of adenomyosis in women who have undergone these procedures.
• Weakening of the Uterine Wall: Certain conditions or factors might weaken the uterine wall, making it more susceptible to endometrial invasion.

Cellular or Tissue Origin Theories

Other theories propose that adenomyosis originates from cells within the uterine wall itself, rather than from an invasion from the lining.

• Metaplasia: This theory suggests that cells in the myometrium, under certain influences, can transform into endometrial-like cells. The exact triggers for this transformation are not fully understood but might involve hormonal or inflammatory signals.
• Müllerianosis: This refers to the presence of endometrial tissue in abnormal locations outside the uterus, and adenomyosis could be considered a form of this when the tissue is within the uterine wall. It is thought to arise from remnants of embryonic tissue.

Hormonal Influence

Estrogen is believed to play a significant role in the development and growth of adenomyosis. Endometrial tissue, including the misplaced tissue in adenomyosis, contains estrogen receptors and responds to estrogen by thickening and bleeding. Higher levels of estrogen, or increased sensitivity to estrogen, are thought to promote the growth of adenomyotic lesions. This is why symptoms often worsen with age until menopause, when estrogen levels naturally decline.

Genetic Predisposition

There is some evidence suggesting a genetic component to adenomyosis. Women with a family history of adenomyosis or other related gynecological conditions, such as endometriosis, may have an increased risk of developing the condition. Research is ongoing to identify specific genes that might be involved.

Inflammation and Immune Factors

Chronic inflammation within the uterus or alterations in the immune system's response may also contribute to adenomyosis. The immune system typically helps to clear away misplaced tissue, but if this process is impaired, endometrial cells might be allowed to proliferate within the myometrium.

Risk Factors

Several factors are associated with an increased risk of developing adenomyosis:

• Age: Most commonly diagnosed in women between their late 30s and early 50s.
• Childbearing: Women who have had at least one pregnancy are more likely to develop adenomyosis than those who have not. Multiple pregnancies and higher parity (number of births) are also associated with increased risk.
• Previous Uterine Surgery: As mentioned, C-sections, myomectomies, and D&Cs can increase the risk.
• Endometriosis: There is a strong association between adenomyosis and endometriosis, another condition where endometrial-like tissue grows outside the uterus. Many women have both conditions.
• Certain Medications: Tamoxifen, a medication used to treat breast cancer, has been linked to adenomyosis.

Diagnosis and Treatment Considerations

Diagnosing adenomyosis can be challenging as symptoms can overlap with other conditions like uterine fibroids. Imaging techniques such as ultrasound and MRI are crucial for diagnosis. Definitive diagnosis traditionally required a hysterectomy (surgical removal of the uterus) and examination of the uterine tissue. However, advanced imaging has improved non-invasive diagnostic capabilities.

Treatment strategies vary depending on the severity of symptoms, the patient's age, and her desire for future fertility. Options range from hormonal therapies to manage symptoms to surgical interventions, including hysterectomy in severe cases.